Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 04/04/2018

2018 American Association for Cancer Research (AACR) Annual Meeting

Schedule of DCTD Presentations

Several members of DCTD’s staff will present information at the AACR Annual Meeting External Link in Chicago, IL, April 14-18, 2018.

Oral Presentations

Time Title Presenter Location
Sunday, April 15
1:45 PM – 3:15 PM Helping Extramural Innovators Advance New Therapies into the Clinic: NCI Developmental Therapeutics Program External Link Jerry Collins, PhD
Rosemarie Aurigemma, PhD
Paul Grothaus, PhD
Suzanne Forry, PhD
Connie Sommers, PhD
Developmental Therapeutics Program
Room W192
3:20 PM – 3:35 PM The National Cancer Institute's patient-derived models repository (PDMR) External Link Yvonne Evrard, PhD
Developmental Therapeutics Program
Room S405
Monday, April 16
1:45 PM – 2:45 PM NCI Cancer Diagnosis Program Initiatives and Resources External Link Aniruddha Ganguly, PhD
Lyndsay Harris, MD
Mickey Williams, PhD
Cancer Diagnosis Program
Room W192
3:00 PM – 5:00 PM Real World Evidence in Oncology and its Implications External Link Elad Sharon, MD, MPH
Cancer Therapy Evaluation Program
Room S401bcd
Tuesday, April 17
10:30 AM – 12:30 PM Funding Opportunities for Cancer Research at Multiple NIH Institutes and Centers External Link Julia Arnold, PhD, Translational Research Program
Sundar Venkatachalam, PhD, Developmental Therapeutics Program
Room W192
12:30 PM – 2:30 PM Technology Transfer and Intellectual Property: Career Opportunities for Scientists External Link Jason Cristofaro, PhD, JD
Office of the Director
Room W192
1:00 PM – 3:00 PM Pediatric Cancer Working Group Scientific Session: Presentations from the NCI Pediatric Preclinical Testing Consortium and the ITCC Pediatric Preclinical Proof-of-Concept Program External Link Malcolm A. Smith, MD, PhD
Cancer Therapy Evaluation Program
Room S404

Poster Presentations

Time Title Location
Sunday, April 15
1:00 PM – 5:00 PM CML as a prototypical malignancy External Link Section 8; Abstract 207/7
Monday, April 16
8:00 AM – 12:00 PM The PDX Data Commons and Coordinating Center (PDCCC) for PDXNet External Link Section 2; Abstract 1029/2
8:00 AM – 12:00 PM Xenograft-associated B cell lymphoproliferative disease as a surrogate model to study Epstein Barr virus (EBV) driven lymphoma of the elderly External Link Section 2; Abstract 1038/11
8:00 AM – 12:00 PM PDX Models generated from a patient with metastatic colon adenocarcinoma display both spatial and temporal tumor heterogeneity External Link Section 2; Abstract 1039/12
8:00 AM – 12:00 PM Activity of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT is associated with drug sensitivity in specific cancer subtypes External Link Section 12; Abstract 1282/5
1:00 PM – 5:00 PM Pediatric Preclinical Testing Consortium evaluation of a DLL3-targeted antibody drug conjugate rovalpituzumab tesirine, in neuroblastoma External Link Section 43; Abstract LB-136/2
Tuesday, April 17
8:00 AM – 12:00 PM Pediatric Preclinical Testing Consortium evaluation of the menin inhibitor, VTP-50469, against xenograft models of MLL-rearranged infant acute lymphoblastic leukemia External Link Section 7; Abstract 3187/19
8:00 AM – 12:00 PM Standardization and coordination of variant interpretation knowledgebases improves clinical genome actionability External Link Section 12; Abstract 3282/13
1:00 PM – 5:00 PM Cryogenic biopsy device for preservation of labile biomarkers External Link Section 24; Abstract 4537/22
1:00 PM – 5:00 PM NCI’s Expert-Vetted Biospecimen Evidence-Based Practices (BEBP): A resource for harmonization of biospecimen collection procedures External Link Section 35; Abstract 4763/7
1:00 PM – 5:00 PM Intratumoral levels of BAX-BAK heterodimer as a specific on-target pharmacodynamic biomarker of drug action by novel BH3 mimetics External Link Section 41; Abstract 4920/16
1:00 PM – 5:00 PM Neuro-endocrine negative SCLC is mostly RB1 WT and may be sensitive to CDK4/6 inhibition, especially if CCND1 is amplified External Link Section 41; Abstract 4932/28
Wednesday, April 18
8:00 AM – 12:00 PM Pediatric Preclinical Testing Consortium (PPTC) of eribulin in osteosarcoma (OS) patient-derived xenograft (PDX) models External Link Section 39; Abstract 5872/19

Meet-the-Expert Presentations — NCI Exhibit Booth # 1400

Time Topic Presenter
Sunday, April 15
3:00 – 3:30 PM Specialized Programs of Research Excellence (SPOREs): Translation Without Hesitation Peter Ujhazy, MD, PhD
Translational Research Program
3:30 – 4:00 PM NCI’s National Clinical Trials Network Navigator: A Clinical Trials Specimen Resource Grace Mishkin, MPH
Cancer Therapy Evaluation Program
Monday, April 16
11:30 AM – 12:00 PM What’s New with the NCI-Pediatric MATCH Trial in 2018? Nita Seibel, MD
Cancer Therapy Evaluation Program
1:30 – 2:00 PM NCI’s Experimental Therapeutics Clinical Trials Network Jeffrey Moscow, MD
Cancer Therapy Evaluation Program
2:00 – 2:30 PM The NCI Formulary: A Cancer Moonshot Initiative Jason Cristofaro, PhD, JD
Office of the Director
Tuesday, April 17
11:30 AM – 12:00 PM Screening Single Agents and Combinations in Complex Spheroids Beverly Teicher, PhD
Developmental Therapeutics Program
1:30 – 2:00 PM NCI’s Cancer Complementary and Alternative Medicine Programs and Activities Libin Jia, MD
Office of Cancer Complementary and Alternative Medicine
2:00 – 2:30 PM NCI Pharmacodynamics Biomarker Program Katherine Ferry-Galow, PhD
Developmental Therapeutics Program
2:30 – 3:00 PM Cancer Biomarker Assay Development & Funding Opportunities: A Cancer Diagnosis Program Initiative Aniruddha Ganguly, PhD
Cancer Diagnosis Program
3:30 – 4:00 PM Cancer Immunotherapy Biomarker Network (CIMACs and CIDC) Magdalena Thurin, PhD
Cancer Diagnosis Program
Helen Chen, MD
Cancer Therapy Evaluation Program

DCTD Staff Kiosk Schedule — Cancer Treatment and Diagnosis — NCI Exhibit Booth #1400

Time DCTD Staff
Sunday, April 15
1:00 – 3:00 PM Aniruddha Ganguly, PhD
Cancer Diagnosis Program
3:00 – 5:00 PM Julia Arnold, PhD
Peter Ujhazy, MD, PhD
Translational Research Program
Monday, April 16
9:00 – 11:00 AM Nina Lukinova, PhD
Cancer Diagnosis Program
11:00 AM – 1:00 PM Libin Jia, MD
Office of Cancer Complementary and Alternative Medicine
1:00 – 3:00 PM Darrell Tata, PhD
Cancer Imaging Program
3:00 – 5:00 PM Steve Nothwehr, PhD
Translational Research Program
Tuesday, April 17
9:00 – 11:00 AM Beverly Teicher, PhD
Developmental Therapeutics Program
11:00 AM – 1:00 PM Igor Kuzmin, PhD
Translational Research Program
1:00 – 3:00 PM Magdalena Thurin, PhD
Cancer Diagnosis Program
3:00 – 5:00 PM Suzanne Forry, PhD
Developmental Therapeutics Program
Wednesday, April 18
9:00 AM – 12:00 PM Aniruddha Ganguly, PhD
Cancer Diagnosis Program